Acquisition to Double Chain Size/Cement Largest Clinic in Arizona
VANCOUVER, BC, May 11, 2021 – Delic Holdings Inc. (“DELIC” or “the “Company“) (CSE: DELC) (OTCQB: DELFC) a psychedelic wellness platform, is pleased to announce that its acquisition target (under binding letter agreement see news release dated February 4, 2021), Ketamine Infusion Centers (“KIC”), proposes to acquire two (2) additional licensed ketamine clinics in Arizona. The proposed acquisition would double the footprint of the infusion chain and become the largest operator in the state of Arizona.
“This is a major step toward becoming the largest ketamine clinic operator in the country, bringing superior quality and expanding access for patients,” said Matt Stang, Delic CEO and co-founder. “KIC is the leading name in high quality care and incredible outcomes for its patients and this move helps grow that reputation significantly. As a vital part of the Delic platform, KIC will continue to offer wellness and benefits for many people suffering from anxiety, depression and PTSD.”
Sonny Diaz, co-founder of KIC, stated: “We are thrilled to join the Delic family and double our footprint with this acquisition, allowing greater access to patients for these vital services. Ketamine Infusion Centers unique model and passion to obtain the highest patient outcomes and purely evidence-based practices is a perfect fit in the Delic ecosystem. Together with their vast knowledge of psychedelic wellness, strong partner channels and mission to bring psychedelic wellness into the mainstream, we see unlimited potential of how many lives we may positively affect together.”
As part of these two sublease transactions, KIC will assume ownership of both licences, which contain the OTC licenses for the respective locations at no additional costs. KIC will submit the necessary paperwork to the State of Arizona to complete the license transfer processes.
About Ketamine Infusion Centers
Ketamine Infusion Centers (“KIC”) is a limited liability corporation formed under the laws of Arizona, which owns and operates two ketamine infusion treatment clinics, one in Phoenix, Arizona and the other in Bakersfield, California. Supported by clinical trials and peer reviewed studies, ketamine infusions have emerged as a promising treatment option for chronic diseases and pain disorders.
DELIC Always Expanding. In All Ways.
DELIC is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio, Complex Biotech Discovery Ventures (under binding acquisition agreement) the first licensed entity by Health Canada to conduct research and development of psilocybin vaporization technology, MeetDelic the premiere psychedelic wellness event, and Ketamine Infusion Centers (under binding acquisition agreement), one of the largest ketamine clinics in the country. DELIC is backed by a team of industry and cannabis veterans and a network whose mission is to provide education, research, high-quality products, and treatment options to the wellness and psychedelics industries.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release.